The global market for cytotoxicity assays is projected to register a Y-o-Y increase of 8.4% in 2022 to be valued at USD 13,803.92 Million. As of 2021, cytotoxicity assays demand was valued at USD 12,732.37 Million. During the 2022 to 2032 assessment period, the industry is likely to expand at a CAGR of 9.1%.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | USD 12,732.37 Million |
| Expected Market Value (2022) | USD 13,803.92 Million |
| Anticipated Forecast Value (2032) | USD 32,978.94 Million |
| Projected Growth Rate (2022 to 2032) | 9.1% CAGR |
Cytotoxicity assays are primarily used to determine the effects of hazardous substances or physiological changes in cell type health. Cytotoxicity assays are the most commonly used tool for quantifying cell exposure to a cytotoxic stimulus.
Furthermore, cytotoxicity assays can be used to determine metabolic activity, cell growth inhibition, or cell division. The Cytotoxicity Assay also assists analysts and clinicians in determining the toxicity level of a specific medication or drugs to be used in the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
One of the most important indicators used in the biological evaluation system is the cytotoxicity assay. Many experimental methods for evaluating cell cytotoxicity are constantly being developed and modernized as modern cell biology advances.
Furthermore, some manufacturers have developed real-time and dynamic methods for quantifying cell morphology, proliferation, and differentiation in cytotoxicity assays.
Following this, other players are attempting to incorporate new real-time cell analysis system technologies into in vitro cytotoxicity tests of medical devices in order to meet the objectives of various tests and also to evaluate the accuracy of in vitro cytotoxicity assays.
One significant disadvantage is the lack of uniform cytotoxicity test methods. Aside from that, there is no standardized protocol for performing cytotoxicity assays.
Principal Consultant
During the forecast period, North America is expected to hold one of the largest shares of the global cytotoxicity assays market. The region's drivers include an increase in haematology and cell proliferation studies, oncology studies, and a variety of other cell-based studies.
According to Future Market Insights, Asia-Pacific countries, particularly India and China, are expected to grow at a significant rate over the assessment period.
Factors such as a significant increase in the import of these assay kits from leading global manufacturers, as well as the presence of local manufacturers with R&D facilities in the region will drive the growth of the cytotoxicity assays market in this region.
Japan, with its high R&D investments in medical devices and well-established healthcare infrastructure, will pave the way for the country's cytotoxicity assay market to grow.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key participants present in the global Cytotoxicity Assays market include F. Hoffman-La Roche AG Thermo Fisher Scientific, Inc, Danaher Corporation, Sakura Finetechnical Co., Ltd and Laboratory Corporation of America Holdings Merck KGaA among others.
Attributed to the presence of such high number of participants, the market is highly competitive.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9.1% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Application, End User, Region |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Russia, Australia & New Zealand, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, GCC, South Africa |
| Key Companies Profiled | F. Hoffman-La Roche AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Sakura Finetechnical Co., Ltd; Laboratory Corporation of America Holdings; Merck KGaA |
| Customization | Available Upon Request |
FMI projects the global Cytotoxicity Assays market to expand at a 9.1% value CAGR by 2032
Asia Pacific is expected to be the most opportunistic Cytotoxicity Assays market.
F. Hoffman-La Roche AG Thermo Fisher Scientific, Inc, Danaher Corporation and Sakura Finetechnical Co., Ltd, are some prominent Cytotoxicity Assays manufacturers
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product Type 6.2. Application 6.3. User Type 7. Global Market Analysis and Forecast, By Product Type 7.1. Cytotoxicity Assay Based Kits 7.2. Colorimetric Cytotoxicity Based Assays Kits 7.3. Fluorometric Cytotoxicity Based Assays Kits 7.4. Elisa Kits 7.5. Crystal Violet Kits 7.6. Minimal Inhibitory Concentration Cytotoxicity Assay Kits 8. Global Market Analysis and Forecast, By Application 8.1. for Nephrotoxicity 8.2. for Cardiotoxicity 8.3. for Apoptosis 8.4. for Cell Proliferation 8.5. for Immunohistochemistry 8.6. for Reporter Genes 8.7. for Transfection Efficacy 8.8. for Other Applications 9. Global Market Analysis and Forecast, By User Type 9.1. for Hospitals 9.2. for Diagnostics Centers 9.3. for Academic & Research Laboratories 9.4. for Pharma & Biotech Companies 9.5. for Other End User Types 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. South Asia 10.5. East Asia 10.6. Oceania 10.7. Middle East & Africa 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Europe Sales Analysis and Forecast, by Key Segments and Countries 14. South Asia Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. Oceania Sales Analysis and Forecast, by Key Segments and Countries 17. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Product Type, Application, and User Type for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. F. Hoffman-La Roche AG 20.2. Thermo Fisher Scientific Inc. 20.3. Danaher Corporation 20.4. Sakura Finetechnical Co., Ltd 20.5. Laboratory Corporation of America Holdings 20.6. Merck KGaA
Explore Healthcare Insights
View Reports
Cytotoxicity Assays Market
